Philips recalled 73 CT systems on August 13, 2025, due to a risk of the patient support table descending unexpectedly. The recall affects models 728240, 728246, and 728256 distributed worldwide. This recall includes systems sold across the US and several countries globally.
The patient support table (couch) may descend unexpectedly to the lowermost position due to a component (ball screw) misalignment after a replacement.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Philips North America Llc or your healthcare provider for instructions. Notification method: Letter
The recalled models include Brilliance 16 Power (Model Number: 728240), Brilliance CT 16 Slice (Model Number: 728246), and Brilliance CT 6 Slice (Model Number: 728256). These CT systems were distributed worldwide, including the United States, and sold at multiple healthcare facilities. The quantity recalled is 73 units.
The patient support table may descend unexpectedly to the lowermost position due to a misalignment of the ball screw component after a replacement. This malfunction presents a serious risk of injury to patients during scans.
The recall is classified as Class II due to the high risk associated with the malfunction. No specific injuries or incidents have been reported at this time.
Patients and healthcare providers must stop using the identified models immediately. Follow the recall instructions provided by Philips and contact Philips North America LLC or your healthcare provider for further instructions.
For more information, contact Philips North America at the provided recall link: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2596-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.